Rafael Santana-Davila, MD

Swedish Cancer Institute

Board-certified medical oncologist

Published Articles (1)

Small Cell Lung Cancer in 2026: Tarlatamab Changes the Arc, and a New Wave of ADCs Is Coming

July 16, 2026

Tarlatamab has changed the arc of small cell lung cancer — the first treatment in years to improve survival in the second-line setting. Dr. Rafael Santana-Davila maps the 2026 landscape and the ADC wave that's coming.